A Landmark Ruling: Celebrating 10 Years of Freedom from Gene Patenting.

Tuesday, June 13, 2023

2:00am PDT

1 hour

Join us for a legendary roundtable as we bring together genetic counselors, patients, and attorneys to share their reflections on the impact of this transformative case.

Hear from panelists who played a significant role in advocating for gene freedom as they discuss:

The heart-breaking challenges patients faced before the 2013 SCOTUS decision invalidating the patents on the BRCA genes
The life-saving impact that access to testing by labs across the country has had for breast and ovarian cancer patients and previvors
The significant drop in cost for BRCA 1&2 testing
New insights on variants and clinical impact enabled by research access to the BRCA1 and BRCA2 genes

Elizabeth Chao

Chief Medical Officer, Ambry Genetics

Elizabeth Chao, MD, FACMG is a Clinical Geneticist who is also board-certified in Clinical Molecular Genetics. She completed her training at the Children’s Hospital of Philadelphia and has nearly ten years of experience in the clinical laboratory. Currently she is on faculty at the University of California, Irvine as an attending Geneticist where she directs the Hereditary Cancer Predisposition clinic, and Dr. Chao is also the Chief Medical Officer at Ambry Genetics. She served on the ACMG Laboratory Quality Assurance Committee from 2015-2020, and been deeply involved in effort through ACMG as well as ClinGen to develop professional standards for clinical laboratory testing and variant assessment.